Xylem (XYL) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $1.46
- EPS estimate
- $1.34
- EPS surprise
- +9.18%
- Revenue surprise
- −0.24%
- Revenue
- $2.3B
- Revenue estimate
- $2.3B
- Reported
- Jul 28, 2026
Xylem reported Q2 2026 results on July 28, 2026. Earnings per share were $1.46, ahead of the $1.34 estimate by 9.18%. Revenue was about $2.3 billion, in line with the $2.3 billion consensus. Compared with Q2 2025, EPS rose about 16% from $1.26, while revenue was level at about $2.3 billion.
The longer record shows steady growth. Annual EPS rose from $2.84 in 2022 to $3.68 in 2023, $4.28 in 2024 and $5.08 in 2025, about 79% over three years. The first half of 2026 adds up to $2.58, about 13% more than the first half of 2025. Quarterly revenue stood near $1.3 billion through 2022 and stepped up during 2023, reaching $2.1 billion by Q3 2023. It has stayed between $2.0 billion and $2.4 billion since. Q2 2026 set the EPS high in the table, while Q1 2022 was the low at $0.47. Xylem beat the EPS estimate in all 20 quarters shown.
Xylem reported Q3 results between October 28 and November 2 in each of the last five years. That points to late October or early November 2026 for the next report. It will show whether year-over-year EPS growth continues into Q3.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 28, 2026 | $1.34 | $1.46 | +9.18% | $2.3B | SEC |
| Q1 2026 | Apr 28, 2026 | $1.08 | $1.12 | +3.24% | $2.1B | SEC |
| Q4 2025 | Feb 10, 2026 | $1.41 | $1.42 | +0.82% | $2.4B | SEC |
| Q3 2025 | Oct 28, 2025 | $1.23 | $1.37 | +11.12% | $2.3B | SEC |
| Q2 2025 | Jul 31, 2025 | $1.15 | $1.26 | +9.74% | $2.3B | SEC |
| Q1 2025 | Apr 29, 2025 | $0.95 | $1.03 | +7.86% | $2.1B | SEC |
| Q4 2024 | Feb 4, 2025 | $1.12 | $1.18 | +4.90% | $2.3B | SEC |
| Q3 2024 | Oct 31, 2024 | $1.11 | $1.11 | +0.07% | $2.1B | SEC |
| Q2 2024 | Jul 30, 2024 | $1.05 | $1.09 | +3.63% | $2.2B | SEC |
| Q1 2024 | May 2, 2024 | $0.84 | $0.90 | +7.33% | $2.0B | SEC |
| Q4 2023 | Feb 6, 2024 | $0.96 | $0.99 | +3.61% | $2.1B | SEC |
| Q3 2023 | Oct 31, 2023 | $0.89 | $0.99 | +11.75% | $2.1B | SEC |
| Q2 2023 | Aug 2, 2023 | $0.82 | $0.98 | +20.08% | $1.7B | SEC |
| Q1 2023 | May 4, 2023 | $0.62 | $0.72 | +16.47% | $1.4B | SEC |
| Q4 2022 | Feb 7, 2023 | $0.79 | $0.92 | +16.03% | $1.5B | SEC |
| Q3 2022 | Nov 1, 2022 | $0.66 | $0.79 | +19.77% | $1.4B | SEC |
| Q2 2022 | Aug 2, 2022 | $0.54 | $0.66 | +22.77% | $1.4B | SEC |
| Q1 2022 | May 4, 2022 | $0.41 | $0.47 | +14.27% | $1.3B | SEC |
| Q4 2021 | Feb 3, 2022 | $0.61 | $0.63 | +2.69% | $1.3B | SEC |
| Q3 2021 | Nov 2, 2021 | $0.59 | $0.63 | +6.45% | $1.3B | SEC |
Quarterly revenue
Frequently asked questions
When did Xylem (XYL) last report earnings?
Xylem last reported on Jul 28, 2026, covering fiscal Q2 2026.
Did XYL beat earnings estimates?
Yes. Xylem reported EPS of $1.46 for Q2 2026 against a $1.34 estimate — a 9.18% beat.
How much revenue did XYL report last quarter?
Xylem reported $2.3B in revenue for Q2 2026, against a consensus estimate of $2.3B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.